| 國立成功大學 |
2023 |
Radiotherapy versus low-dose tamoxifen following breast-conserving surgery for low-risk and estrogen receptor-positive breast ductal carcinoma in situ: an international open-label randomized non-inferiority trial (TBCC-ARO DCIS Trial)
|
Kuo, S.-H.;Tseng, L.-M.;Chen, S.-T.;Sagara, Y.;Chang, Y.-C.;Yeh, H.-T.;Kuo, Y.-L.;Hung, C.-C.;Lu, T.-P.;Lee, Y.-H.;Toi, M.;Huang, C.-S. |
| 國立成功大學 |
2023 |
The role of LSM1 in breast cancer: Shaping metabolism and tumor-associated macrophage infiltration
|
Tzeng, Y.-D.T.;Hsiao, J.-H.;Chu, P.-Y.;Tseng, L.-M.;Hou, M.-F.;Tsang, Y.-L.;Shao, A.-N.;Sheu, J.J.-C.;Li, C.-J. |
| 臺大學術典藏 |
2022-08-23T02:35:03Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Dai M.-S.; Liu L.-C.; Wang M.-Y.; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; SUNG-HSIN KUO; Huang C.-S.; Yeh D.-C.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Lin P.-H. |
| 臺大學術典藏 |
2022-08-12T06:27:35Z |
EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid
|
Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; Kuo W.-H.; KING-JEN CHANG; Lin Y.-C.; Tseng L.-M.; Hou M.-F. |
| 臺大學術典藏 |
2022-07-29T03:18:01Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin P.-H.; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; Lin C.-H.; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; MING-YANG WANG; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2022-07-29T03:18:01Z |
Neoadjuvant afatinib with paclitaxel for triple-negative breast cancer and the molecular characteristics in responders and non-responders
|
Lin P.-H.; Tseng L.-M.; Lee Y.-H.; Chen S.-T.; Yeh D.-C.; Dai M.-S.; Liu L.-C.; MING-YANG WANG; Lo C.; Chang S.; Tan K.T.; Chen S.-J.; Kuo S.-H.; Huang C.-S. |
| 臺大學術典藏 |
2022-05-11T08:25:41Z |
Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients
|
Lin P.-H.; Chen S.-C.; Tseng L.-M.; Chang K.-J.; Huang A.-C.; Cheng K.-C.; Yang K.; Wu H.-C.; Chao T.-Y.; Chang Y.-C.; Lin P.-C.; Kuo W.-H.; Kuo W.-L.; CHING-HUNG LIN; Chen H.-M.; Yeh D.-C.; Liu L.-C.; Liu C.-Y.; Wang M.-Y.; Lo C.; Lu Y.-S.; Huang C.-S. |
| 臺大學術典藏 |
2022-05-05T09:10:22Z |
International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases
|
Chow E.; Nguyen J.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; Alm El-Din M.A.; Kumar A.; Forges F.; WEI-CHU CHIE; Bottomley A. |
| 臺大學術典藏 |
2022-05-05T09:10:20Z |
Quality of life after palliative radiation therapy for patients with painful bone metastases: Results of an international study validating the EORTC QLQ-BM22
|
Zeng L.; Chow E.; Bedard G.; Zhang L.; Fairchild A.; Vassiliou V.; Alm El-Din M.A.; Jesus-Garcia R.; Kumar A.; Forges F.; Tseng L.-M.; Hou M.-F.; WEI-CHU CHIE; Bottomley A. |
| 臺大學術典藏 |
2022-05-05T09:10:19Z |
An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases
|
Zeng L.; Chow E.; Zhang L.; Tseng L.-M.; Hou M.-F.; Fairchild A.; Vassiliou V.; Jesus-Garcia R.; El-Din M.A.A.; Kumar A.; Forges F.; WEI-CHU CHIE; Bedard G.; Bottomley A. |
